|
summary: This study suggests that dehydroepiandrosterone and its sulphated conjugate should be considered as biological markers of fatigue in MS patients and that hormone replacement may thus be tested as an option to treat fatigue in MS patients.
authors: Tellez N, Comabella M, Julia E, Rio J, Tintore M, Brieva L, Nos C, Montalban X.
source: Mult Scler. 2006 Aug;12(4):487-94.
weblink: click here
category: Symptomatic Treatments and Rehabilitation
related research news: click here
glossary:
ACE
Fatigue
Multiple sclerosis
Physical
Sclerosis
|
